Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 6,596 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

RPKM, FPKM and TPM, clearly explained

How to Analyze RNA-Seq Data?

Visualization of nucleotide substitutions in the (micro)transcriptome

Comparison of TMM (edgeR), RLE (DESeq2), and MRN Normalization Methods

An RNA-Seq QC Overview

PlaqView 2.0 – A comprehensive web portal for cardiovascular single-cell genomics

Sample-multiplexing approaches for single-cell sequencing

Researchers use single-cell approaches and deep learning to map all stages of fruit fly embryo development

DeLTa-Seq – direct-lysate targeted RNA-Seq from crude tissue lysate

Tumor bulk-RNA seq identifies patients at high risk of progression in non-complete pathological responders from NADIM trial

PlaqView 2.0 – A comprehensive web portal for cardiovascular single-cell genomics

Sample-multiplexing approaches for single-cell sequencing

Researchers use single-cell approaches and deep learning to map all stages of fruit fly embryo development

DeLTa-Seq – direct-lysate targeted RNA-Seq from crude tissue lysate

Tumor bulk-RNA seq identifies patients at high risk of progression in non-complete pathological responders from NADIM trial

STRIDE – a topic-model-based method to deconvolve spatial transcriptomics using scRNA-seq

Researchers find heart failure arises from mutations in numerous distinct genes